Pharmaceutical Articles

RSS | Login | Register

Merck, Healthy Interactions expand diabetes education program

Ben Comer June 05, 2008

Merck and Healthy Interactive will expand diabetes education for patients through their US Diabetes Conversation Map Program, which includes a new Spanish language launch.

Poll: docs say don't take away CME support

Matthew Arnold June 04, 2008

A poll of 268 physicians found that 92% disagree with an AMA committee's call to end commercial support of CME.

Ads blast Merck on AIDS drug prices in Mexico

Matthew Arnold May 30, 2008

The AIDS Healthcare Foundation launched a print ad aimed at shaming Merck in its own neighborhood for the prices it charges for AIDS drug Stocrin (Sustiva) in Mexico.

FDA proposes Rx label revisions for moms

Stephen McGuire May 29, 2008

The FDA on Wednesday announced it is proposing revisions to physician labeling for Rx drugs to include more info about their use by pregnant and/or breast-feeding mothers.

GSK blood drug works same as placebo: FDA

Stephen McGuire May 28, 2008

GlaxoSmithKline's (GSK) experimental drug Promacta (eltrombopag) failed to significantly lower bleeding in patients with the rare blood disorder it was designed to treat, the FDA said.

New FDA plan to monitor drug safety

Stephen McGuire May 23, 2008

US health officials Thursday announced the launch of a new system to better monitor the side effects of marketed pharmaceuticals.

IMS projects seven potential blockbusters

Ben Comer May 22, 2008

Seven potential blockbusters could emerge in 2008, according to IMS Health.

Merck agrees to pre-approval of TV ads in Vioxx settlement

Matthew Arnold May 22, 2008

Merck has agreed to submit all TV ads to the FDA before running them and to adhere to agency recommendations on them as part of a Vioxx-related settlement.

Lilly shuffles marketing personnel

Stephen McGuire May 21, 2008

Eli Lilly will consolidate its global and international marketing organizations as the drugmaker undergoes a companywide initiative to reduce management layers.

Product news

May 20, 2008

Bayer HealthCare Pharmaceuticals announced that a reformulation of the liquid Leukine (sargramostim) has been approved by FDA and is now available for patients and physicians in the US.

« Previous

Most Emailed

Most Recent

RSS